MIND Act of 2025
The source supplies the latest action, but no lifecycle stage.
Latest action (29 Sep 2025): Read twice and referred to the Committee on Commerce, Science, and Transportation. (text: CR S6834-3836)
What this bill does
The proposed bill, S. 2925, known as the MIND Act of 2025, would direct the Federal Trade Commission (FTC) to study the governance of neural data and other related data. This study would examine existing laws, identify potential gaps, and assess best practices for privacy and data security. The FTC would also be tasked with proposing a regulatory framework to balance innovation with the risks of harm, such as discrimination and manipulation.
The bill specifically defines neural data as information gathered from measuring the nervous system through neurotechnology, and "other related data" as biometric or behavioral information that can infer cognitive or emotional states. The study's findings and recommendations would be submitted to Congress in a report, which would also be published online.
S. 2925 was introduced in the Senate on September 29, 2025, by Senator Charles Schumer and others. It has been referred to the Committee on Commerce, Science, and Transportation. Following the FTC's report, the Director of the Office of Science and Technology Policy, in consultation with the FTC and the Office of Management and Budget, would develop guidance for Federal agencies on the use of neurotechnology. This guidance would then become binding for agencies.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
29 Sep 2025
Read twice and referred to the Committee on Commerce, Science, and Transportation. (text: CR S6834-3836)
Common questions
- What does S. 2925 do?
- The proposed bill, S. 2925, known as the MIND Act of 2025, would direct the Federal Trade Commission (FTC) to study the governance of neural data and other related data. This study would examine existing laws, identify potential gaps, and assess best practices for privacy and data security. The FTC would also be tasked with proposing a regulatory framework to balance innovation with the risks of harm, such as discrimination and manipulation. The bill specifically defines neural data as information gathered from measuring the nervous system through neurotechnology, and "other related data" as biometric or behavioral information that can infer cognitive or emotional states. The study's findings and recommendations would be submitted to Congress in a report, which would also be published online. S. 2925 was introduced in the Senate on September 29, 2025, by Senator Charles Schumer and others. It has been referred to the Committee on Commerce, Science, and Transportation. Following the FTC's report, the Director of the Office of Science and Technology Policy, in consultation with the FTC and the Office of Management and Budget, would develop guidance for Federal agencies on the use of neurotechnology. This guidance would then become binding for agencies.
- Has S. 2925 become law?
- The source does not supply a confirmed lifecycle stage for S. 2925. Check the latest action and official source below.
- Who sponsored S. 2925?
- S. 2925 was sponsored by Sen. Schumer, Charles E. [D-NY] (D-NY), with 2 cosponsors.
- What's the latest action on S. 2925?
- Read twice and referred to the Committee on Commerce, Science, and Transportation. (text: CR S6834-3836) (29 Sep 2025).
Related bills in Commerce
Critical Infrastructure Manufacturing Feasibility Act
Cybersecurity for Small Businesses Act of 2026
Small Business Payment for Performance Act of 2026
Combating Foreign Threats to Main Street Act of 2026
More bills from Sen. Schumer, Charles E. [D-NY]
Restoring Essential Plan Coverage Act
A bill to designate a building of the Chancery of the United States in Pristina, Kosovo, as the "Elliot L. Engel Building".
No Payoffs for Pardons Act
Anti-Corruption Bureau Creation Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.